D.A. Davidson & Co. Edwards Lifesciences Corp Transaction History

D.A. Davidson & Co.

$11.2 Billion
Q2 2024

A detailed history of D.A. Davidson & Co. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, D.A. Davidson & Co. holds 27,089 shares of EW stock, worth $1.77 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

27,089

Previous 27,089 -0.0%

Holding current value

$1.77 Million

Previous $2.59 Million 3.32%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $141,453 - $186,342	-1,950 Reduced 6.72%	27,089 $2.59 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $844,254 - $1.06 Million	-13,681 Reduced 32.02%	29,039 $2.21 Million
Q3 2023 Nov 08, 2023	BUY	$69.28 - $93.38 $38,935 - $52,479	562 Added 1.33%	42,720 $2.96 Million
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $28,005 - $32,449	344 Added 0.82%	42,158 $3.98 Million
Q1 2023 Apr 25, 2023	SELL	$74.26 - $84.51 $222,854 - $253,614	-3,001 Reduced 6.7%	41,814 $3.46 Million
Q4 2022 Feb 03, 2023	SELL	$68.3 - $87.44 $348,944 - $446,730	-5,109 Reduced 10.23%	44,815 $3.34 Million
Q3 2022 Nov 07, 2022	SELL	$82.37 - $107.29 $89,865 - $117,053	-1,091 Reduced 2.14%	49,924 $4.18 Million
Q2 2022 Jul 28, 2022	SELL	$86.5 - $128.27 $18,684 - $27,706	-216 Reduced 0.42%	51,015 $4.85 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $32,831 - $41,325	322 Added 0.63%	51,231 $6.03 Million
Q4 2021 Jan 31, 2022	SELL	$106.37 - $130.68 $177,850 - $218,496	-1,672 Reduced 3.18%	50,909 $6.65 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $2,058 - $2,455	-20 Reduced 0.04%	52,581 $5.95 Million
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $115,280 - $144,045	-1,375 Reduced 2.55%	52,601 $5.45 Million
Q1 2021 May 07, 2021	SELL	$78.68 - $90.67 $433,133 - $499,138	-5,505 Reduced 9.26%	53,976 $4.52 Million
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $246,685 - $313,922	3,441 Added 6.14%	59,481 $5.34 Million
Q3 2020 Nov 02, 2020	SELL	$67.19 - $87.44 $35,879 - $46,692	-534 Reduced 0.94%	56,040 $4.47 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $2.22 Million - $2.97 Million	38,603 Added 214.81%	56,574 $3.91 Million
Q1 2020 May 05, 2020	BUY	$52.41 - $81.0 $8,542 - $13,203	163 Added 0.92%	17,971 $3.5 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $68,688 - $78,642	958 Added 5.69%	17,808 $4.14 Million
Q3 2019 Nov 05, 2019	SELL	$61.55 - $75.43 $2,215 - $2,715	-36 Reduced 0.21%	16,850 $3.71 Million
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $375,520 - $433,930	-6,737 Reduced 28.52%	16,886 $3.12 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $19,156 - $25,620	-400 Reduced 1.67%	23,623 $4.47 Million
Q4 2018 Jan 29, 2019	SELL	$46.41 - $56.94 $20,838 - $25,566	-449 Reduced 1.83%	24,023 $3.68 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $16,589 - $21,064	-363 Reduced 1.46%	24,472 $4.26 Million
Q2 2018 Aug 02, 2018	BUY	$42.45 - $51.3 $24,451 - $29,548	576 Added 2.37%	24,835 $3.62 Million
Q1 2018 May 04, 2018	SELL	$37.19 - $47.45 $5,132 - $6,548	-138 Reduced 0.57%	24,259 $3.39 Million
Q4 2017 Feb 08, 2018	BUY	$33.79 - $39.39 $62,241 - $72,556	1,842 Added 8.17%	24,397 $2.75 Million
Q3 2017 Nov 08, 2017	SELL	$36.29 - $38.83 $49,209 - $52,653	-1,356 Reduced 5.67%	22,555 $2.47 Million
Q2 2017 Aug 11, 2017	BUY	N/A	23,911	23,911 $0

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account